Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Anthera Pharmaceuticals, Inc. (ANTH) had Free Cash Flow per Share of $-3.59 for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
$-29.38M |
|
-- |
|
-- |
|
$36.43M |
|
$-36.43M |
|
$9.56M |
|
$-26.87M |
|
$-26.87M |
|
$-26.87M |
|
$-26.87M |
|
$-26.87M |
|
$-26.87M |
|
$-36.43M |
|
$-36.15M |
|
10.28M |
|
10.28M |
|
$-2.86 |
|
$-2.86 |
|
| Balance Sheet Financials | |
$3.19M |
|
$0.48M |
|
$0.48M |
|
$3.67M |
|
$4.71M |
|
-- |
|
$4.46M |
|
$9.17M |
|
$-5.83M |
|
$-5.50M |
|
$-5.50M |
|
13.85M |
|
| Cash Flow Statement Financials | |
$-36.90M |
|
$0.00M |
|
$18.25M |
|
$20.84M |
|
$2.20M |
|
$-18.65M |
|
$4.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
461.12% |
|
489.06% |
|
-731.66% |
|
489.06% |
|
$-0.40 |
|
|
Free Cash Flow per Share |
$-3.59 |
$-3.59 |
|